More on Mast Therapeutics Q2 results

|About: Mast Therapeutics, Inc. (MSTX)|By:, SA News Editor

Mast Therapeutics (MSTX) Q2 results: Revenues: $0; Net Loss: ($7.2M) (-44.7%); Loss Per Share: ($0.06) (+33.3%); Quick Assets: $46.4M (+4.5%).

No financial guidance given.